Search Results

The Company also provided an update on its most advanced programs for ANAVEX®2-73 for the treatment of Conference Call / Webcast Information Anavex will host a conference call at 4:30 p.m. The live webcast of the conference call can be accessed online at http://wsw.com/webcast/cc/avxl3. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media: Clayton

Rare Diseases: Challenges and Opportunities”, at the Precision in Clinical Trials Virtual Summit (East Coast The Precision in Clinical Trials Virtual Summit (East Coast) takes place May 10th – 11th 2021. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

(OTCQX: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel drug projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Shareholder & Media

clinical proof of ANAVEX®3-71 having same pharmacokinetics in both gender and no food effect Company to host Conference Call Information Anavex Life Sciences will host a webcast today at 8:30 a.m. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Neuro-degenerative diseases, 16(1-2), 95–110. https://doi.org/10.1159/000440864

“This is an important feature since OPCs can replace lost OLs by maturing into new potential myelin-producing (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media

(Nasdaq: AVXL) is a biopharmaceutical company dedicated to the development of differentiated therapeutics projected in any of such statements due to various factors, including the risks set forth in the Company’s most Thomas Jenene Thomas Communications, LLC 908- 938-1475 Email: JTC@jenenethomascommunications.com Media

(Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Investors: Matthew Haines River East Investor Relations, LLC 917-733-9297 mhaines@rivereastir.com Media

Company to host a webcast   today at 8:30 a.m. dihydrogen phosphate salt of ANAVEX®2-73 (blarcamesine), freebase, transdermal patches and enteric coated (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics projected in any of such statements due to various factors, including the risks set forth in the Company’s most

Conference Call / Webcast Information The live webcast of the conference call can be accessed online at http (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

Conference Call / Webcast Information: The live webcast of the conference call can be accessed online at https (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

Rare Diseases: Challenges and Opportunities”, at the Precision in Clinical Trials Virtual Summit (West Coast The Precision in Clinical Trials Virtual Summit (West Coast) takes place Feb 24th– 25th 2021. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

the investigators and clinical site coordinators as well as all the participating families for their dedication (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media